Number | Cited Articles |
1 |
Masakuni Fujii, Toshiki Ozato, Sho Mizukawa, Junichiro Nasu, Haruyuki Kawai, Shin-ichi Fujioka, Masao Yoshioka, Junji Shiode, Kazuhide Yamamoto. A rare case of immunotherapy-induced cholangitis and gastritis. Clinical Journal of Gastroenterology 2020; 13(6): 1083 doi: 10.1007/s12328-020-01218-0
|
2 |
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar, Vanesa Bernal Monterde. Efectos adversos inmunomediados gastrointestinales y hepáticos inducidos por los inhibidores del punto de control inmunitario: estudio descriptivo observacional. Gastroenterología y Hepatología 2020; doi: 10.1016/j.gastrohep.2020.07.009
|
3 |
Albert Alhatem, Krishan Patel, Brenda Eriksen, Sarosh Bukhari, Chen Liu. Nivolumab-Induced Concomitant Severe Upper and Lower Gastrointestinal Immune-Related Adverse Effects. ACG Case Reports Journal 2019; 6(11): e00249 doi: 10.14309/crj.0000000000000249
|
4 |
Shinsuke Otagiri, Takehiko Katsurada, Kana Yamanashi, Kensuke Sakurai, Michiko T Sato, Jun Sakakibara‐Konishi, Naoya Sakamoto. Immune checkpoint inhibitor‐induced enteritis assessed using capsule endoscopy. JGH Open 2020; 4(6): 1231 doi: 10.1002/jgh3.12392
|